MARKET

RGEN

RGEN

Repligen Corp
NASDAQ

Real-time Quotes | Nasdaq Last Sale

96.50
-0.15
-0.16%
After Hours: 96.50 0 0.00% 16:00 04/08 EDT
OPEN
98.14
PREV CLOSE
96.65
HIGH
98.26
LOW
94.52
VOLUME
413.87K
TURNOVER
--
52 WEEK HIGH
109.94
52 WEEK LOW
52.87
MARKET CAP
5.03B
P/E (TTM)
219.82
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 10 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average RGEN stock price target is 112.13 with a high estimate of 120.00 and a low estimate of 98.00.

EPS

RGEN News

More
  • 2 Top U.S. Stocks to Watch in April
  • MotleyFool.com · 7h ago
  • Hedge Funds Are Selling Is Repligen Corporation (RGEN)
  • Insider Monkey · 2d ago
  • The Virus Bears Exit As The Recession Bears Enter, The Next 10 Days Are Pivotal
  • Seeking Alpha - Article · 3d ago
  • Stifel Maintains Buy on Repligen, Lowers Price Target to $113
  • Benzinga · 6d ago

Industry

Medical Equipment, Supplies & Distribution
+4.21%
Healthcare Equipment & Supplies
+4.01%

Hot Stocks

Symbol
Price
%Change

About RGEN

Repligen Corporation is a bioprocessing company. The Company is focused on the development, manufacture and commercialization of products used to improve the interconnected phases of the biological drug manufacturing process. The Company's portfolio includes protein products, chromatography products, and filtration products. It provides Protein A ligands, a component of Protein A chromatography resins (media) used in the purification of virtually all monoclonal antibody (mAb)-based drugs on the market or in development. Its chromatography portfolio includes various products used in the downstream purification and quality control of biological drugs. Its OPUS pre-packed chromatography columns (PPCs) are used in the purification of clinical-stage biologics. Its filtration products include XCell Alternating Tangential Flow (ATF) Systems and Sius tangential flow filtration (TFF) cassettes. Sius TFF cassettes are used to concentrate clinical and commercial-stage biologic drugs.
More

Webull offers kinds of Repligen Corporation stock information, including NASDAQ:RGEN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RGEN stock news, and many more online research tools to help you make informed decisions.